The balance of pro- and anti-inflammatory cytokines in cardiac surgery

Current Opinion in Anaesthesiology

Volumn 11, Issue 1, 1998, Pages 15-22

  McBride, William T ^a,c   McBride, Samuel J ^b  

^a ROYAL VICTORIA HOSPITAL   (United Kingdom)

^b Department of Microbiology Greenwich Hospital   (United Kingdom)

^c DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACETYLCYSTEINE; APROTININ; CYTOKINE; HEPARIN; INTERLEUKIN 10; METHYLPREDNISOLONE; NONSTEROID ANTIINFLAMMATORY AGENT; TRANSFORMING GROWTH FACTOR BETA;

CANCER; CARDIOPULMONARY BYPASS; COLLOID; CRYSTALLOID; CYTOKINE RELEASE; DIABETES MELLITUS; GASTROINTESTINAL TRACT; HEALTH; HEART MUSCLE; HEART SURGERY; HEMOFILTRATION; HOMEOSTASIS; HUMAN; HYPOXIA; IMMUNOSUPPRESSIVE TREATMENT; INFLAMMATION; ISCHEMIC HEART DISEASE; PRIORITY JOURNAL; RESPIRATORY SYSTEM; REVIEW; TEMPERATURE; URINARY TRACT;

EID: 0031964611     PISSN: 09527907     EISSN: None     Source Type: Journal    
DOI: 10.1097/00001503-199802000-00004     Document Type: Review

References (65)

1. McBride WT, McBride SJ. The inflammatory response at cardiac surgery: • implications for the anesthesiologist. Prog Anesthesiol 1997; 11:91-112. A general review of the underlying mechanisms of the inflammatory response.
2. Donnelly SC, Stneter RM, Kunkel SL, Walz A, Robertson CR, Carter DC, et al., Interleukin-8 and development of adult respiratory distress syndrome in at-risk groups. Lancet 1993; 341:643-647.
3. Suter PM, Suter S, Girardin E, Roux-Lombard P, Grau GE, Dayer J. High bronchoalveolar lavage levels of tumour necrosis factor and its inhibitors, interleukin-1, interferon, and elastase in patients with adult respiratory distress syndrome after trauma, shock or sepsis. Am Rev Respir Dis 1992; 145:1016-1022.
4. Donnelly SC, Strieter RM, Reid PT, Kunkel SL, Burdick MD, Armstrong I, et al.. The association between mortality rates and decreased concentrations of interleukin-10 and interleukin-1 receptor antagonist in the lung fluids of patients with adult respiratory distress syndrome. Ann Intern Med 1996; 125:191-196.
5. Armstrong L, Millar AB. Relative production of tumour necrosis factor • alpha and interleukin 10 in adult respiratory distress syndrome. Thorax 1997; 52:442-446. The importance of intrapulmonary cytokine balance is emphasized in the ARDS patient.
6. McBride WT, Armstrong MA, Gilliland H, McMurray TJ. The balance of • pro and anti-inflammatory cytokines in plasma and bronchoalveolar lavage at pediatric cardiac surgery. Cytokine 1996; 8:729-737. The importance of intrapulmonary cytokine balance is emphasized during cardiac surgery.
7. Jorres A, Kordonouri O, Schiessler A, Hess S, Farke S, Gahl GM, et al.. Urinary excretion of thromboxane and markers for renal injury in patients undergoing cardiopulmonary bypass. Artificial Organs 1994; 18:565-569.
8. Liao Z, Grimshaw RS, Rosenstreich DL. Identification of a specific interleukin-1 inhibitor in the urine of febrile patients. J Exp Med 1984; 159:126-136.
9. Rosenstreich DL, Yost SL, Brown KM. Human urine-derived inhibitors of interleukin 1. Rev Infect Dis 1987; 9 (suppl 5):S594-S598.
10. Svenson M. Bendtzen K. Inhibitor of interleukin-1 in normal human urine. Different effects on mouse thymocytes and on a murine T-cell line. Scand J Immunol 1988; 27:593-599.
11. Tullus K, Escobar-Billing R, Fituri O, Burman LG, Karlsson A, Wikstad I, et al.. Interleukin-1 alpha and interleukin-1 receptor antagonist in the urine of children with acute pyelonephritis and relation to renal scarring. Acte Paediatr 1996; 85:158-162.
12. Haraoka M, Senoh K, Ogata N, Furukawa M, Matsumoto T, Kumazawa J. Elevated interleukin-8 levels in the urine of children with renal scarring and/or vesicoureteral reflux. J Urol 1996; 155:678-680.
13. Wu TH, Wu SC, Huang TP, Yu CL, Tsai CY. Increased excretion of tumor necrosis factor alpha and interleukin1 beta in urine from patients with IgA nephropathy and Schonlein-Henoch purpura. Nephron 1996; 74:79-88.
14. Honkanen E, Teppo AM, Meri S. Lehto T, Gronhagen-Riska C. Urinary excretion of cytokines and complement SC5b in idiopathic glomerulonephritis. Nephrol Dial Transplant 1994; 9:1553-1559.
15. Lehto T, Honkanen E, Teppo AM, Meri S. Urinary excretion of protectin (CD59), complement SC5b-9 and cytokines in membranous glomerulonephritis. Kidney Int 1995; 47:1403-1411.
16. Martins SM, Darlin DJ, Lad PM, Zimmern PE. Interleukin-1B: a clinically relevant urinary marker. J Urol 1994; 151:1198-1201.
17. Sprenger H, Jacobs C, Nain M, Gressner AM, Prinz H, Wesemann W, Gemsa D. Enhanced release of cytokines, interleukin-2 receptors, and neopterin after long-distance running. Clin Immunol Immunopathol 1992; 63:188-195.
18. Hyams JS, Fitzgerald JE, Wyzga N, Muller R, Treem WR, Justinich CJ, Kreutzer DL. Relationship of interleukin-1 receptor antagonist to mucosal inflammation in inflammatory bowel disease. J Pediatr Gastroenterol Nutr 1995; 21:419-425.
19. Ito H, Hamano K, Gohra H, Katoh T, Fujimura Y, Tsuboi H, Esato K. • Relationship between respiratory distress and cytokine response after cardiopulmonary bypass. Surg Today 1997; 27:220-225. The relationship between cytokine response and clinical outcome is addressed.
20. Fujiwara T, Seo N, Murayama T, Hirata S, Kawahito K, Kawakami M. Transient rise in serum cytokines during coronary artery bypass graft surgery. Eur Cytokine Netw 1997; 8:61-66.
21. Hubner G, Brauchle M, Smola H, Madlener M, Fassler R, Werner S. Differential regulation of pro-inflammatory cytokines during wound healing in normal and glucocorticoid treated mice. Cytokine 1996; 8:548-556.
22. Malecaze F, Simorre V, Chollet P, Tack JL, Muraine M, Le Guellec D, et al., Interleukin-6 in tear fluid after photorefractive keratectomy and its effects on keratocytes in culture. Cornea 1997; 16:580-587.
23. Miller LC, Lynch EA, Isa S, Logan JW, Dinarello CA, Steere AC. Balance of synovial fluid IL-1 beta and IL-1 receptor antagonist and recovery from Lyme arthritis. Lancet 1993; 341:146-148.
24. Girardin E, Roux-Lombard P, Grau GE, Suter P, Gallati H. Imbalance between tumor necrosis factor alpha and soluble TNF receptor levels in severe meningococcemia. Immunology 1992; 76:20-23.
25. Villard J, Roux-Lombard P, Hugh A, Dayer J-M. Could natural inhibitors of tumor necrosis factor alpha modify the clinical course of fulminant meningococcemia? Crit Care Med 1993; 21:1396-1400.
26. Atwell D, McBride WT, Sorohan J, Grichnik KP, Reves JG, Newman M. The balance of pro- and anti-inflammatory cytokines at thoracic surgery [abstract]. Anesth Analg 1997; 84:SCA20.
27. Deng MC, Wiedner M, Erren M, Mollhoff T, Assmann G, Scheld HH. Arterial and venous cytokine response to cardiopulmonary bypass for low risk CABG and relation to hemodynamics. Eur J Cardiothorac Surg 1995; 9:22-29.
28. Lahat N, Zlotnick Ay, Shtiller R, Bar I, Merin G. Serum levels of IL-1, IL-6 and TNF in patients undergoing coronary artery bypass grafts or cholecystectomy. Clin Exp Immunol 1992; 89:255-260.
29. Butler J, Chong GL, Baigrie RJ, Pillai R, Westaby S, Rocker GM. Cytokine responses to cardiopulmonary bypass with membrane and bubble oxygenation. Ann Thorac Surg 1992; 53:833-838.
30. Jansen NJG, Van Oeveren W, Gu YJ, Van Vliet MJ, Eijsman L, Wildevuur CRH. Endotoxin release and tumor necrosis factor formation during cardiopulmonary bypass. Ann Thorac Surg 1992; 54:744-747.
31. Kawamura T, Wakusawa R, Okada K, Inada S. Elevation of cytokines during open heart surgery with cardiopulmonary bypass: participation of interleukin 8 and 6 in reperfusion injury. Can J Anaesth 1993; 40:1016-1021.
32. Katfin RE, Engelman RM, Rousou JA, Flack JE, Deaton DW, Kreutzer DL, Das DK. Induction of IL-8 expression during cardiopulmonary bypass. Circulation 1993; 88:2401-2406.
33. Haeffner-Cavaillon N, Roussellier N, Ponzio O, Carreno M-P, Laude M, Carpentier A, Kazatchkine MD. Induction of interleukin-1 production in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1989; 98:1100-1106.
34. Tashiro H, Shimokawa H, Yanamoto K, Momohara M, Tada H, Takeshita A. Altered plasma levels of cytokines in patients with ischemic heart disease. Coron Art Dis 1997; 8:143-147.
35. Reinhold D, Ansorge S, Schleicher ED. Elevated glucose levels stimulate transforming growth factor-beta 1 (TGF-beta 1), suppress interleukin IL-2, IL-6 and IL-10 production and DNA synthesis in peripheral blood mononuclear cells. Horm Metab Res 1996; 28:267-270.
36. Markewitz A, Faist E, Lang S, Endres S, Hultner L, Reichart B. Regulation of acute phase response after cardiopulmonary bypass by immunomodulation. Ann Thorac Surg 1993; 55:389-394.
37. Hill GE, Alonso A, Spurzem JR, Stammers AH, Robbins RA. Aprotinin and methylprednisolone equally blunt cardiopulmonary bypass-induced inflammation in humans. J Thorac Cardiovasc Surg 1995; 110:1658-1662.
38. Demek S, Sevin B, Asian R, Kaklillaya I, Atalay C, Kural T. Effects of aprotinin on plasma levels of neutrophil elastase and postoperative blood loss in cardiac surgery. Cardiovasc Surg 1996; 4:515-519.
39. Seghaye MC, Duchateau J, Grabitz RG, Jablonka K, Wenzl T, Marcus C, et al. Influence of low-dose aprotinin on the inflammatory reaction due to cardiopulmonary bypass in children. Ann Thorac Surg 1996; 61:1205-1211.
40. De Backer WA, Amsel B, Jorens PG, Bossaert L, Hiemstra PS, van Noort P, van Overveld FJ. N-acetylcysteine pretreatment of cardiac surgery patients influences plasma neutrophil elastase and neutrophil influx in bronchoalveolar lavage fluid. Intensive Care Med 1996; 22:900-908.
41. Oz MC, Liao H, Naka Y, Seldomride A, Becker DN, Michler RE, et al.. Ischemia-induced interleukin-8 release after human heart transplantation. A potential role for endothelial cells. Circulation 1995; 92:II428-II432.
42. McBride WT, Armstrong MA, Crockard AD, McMurray TJ, Rea JM. The pro- and anti-inflammatory response at cardiac surgery. Contrast between patients and isolated cardiopulmonary bypass circuits. Br J Anaesth 1995; 75:724-733.
43. Chello M, Mastroroberto P, Romano R, Ascione R, Pantaleo D, De Amicis V. Complement and neutrophil activation during cardiopulmonary bypass: a randomized comparison of hypothermic and normothermic circulation. Eur J Cardiothorac Surg 1997; 11:162-168.
44. Menasche P, Haydar S, Peynet J, Du Buit C, Merval R, Bloch G, et al.. A potential mechanism of vasodilation after warm heart surgery. The t>emperature dependent release of cytokines. J Thorac Cardiovasc Surg 1994; 107:293-299.
45. Tonz M, Mihaljevic T, von Segesser LK, Shaw S, Luscher TF, Turina M. Postoperative hemodynamics depend on cardiopulmonary bypass temperature: the potential role of endothelin-1. Eur J Cardiothorac Surg 1997; 11:157-161.
46. Boldt J, Osmer C, Linke LC, Gorlach G, Hempelmann G. Hypothermic versus normothermic cardiopulmonary bypass: influence on circulating adhesion molecules. J Cardiothorac Vasc Anesth 1996; 10:342-347.
47. Steinberg BM, Gossi EA, Schwartz DS, McLoughlin DE, Aquinaga M, Bizekis C, et al.. Heparin bonding of bypass circuits reduces cytokine release during cardiopulmonary bypass. Ann Thorac Surg 1995; 60:525-529.
48. Svennevig JL, Geiran OR, Karlsen H, Pedersen T, Mollnes TE, Kongsgard U, Froysaker T. Complement activation during extracorporeal circulation. In vitro comparison of Duraflo II heparin-coated and uncoated oxygenator circuits. J Thorac Cardiovasc Surg 1993; 106:466-472.
49. Øvrum E, Mollnes TE, Fosse E, Holen EA, Tangen G, Abdelnoor M, et al.. Complement and granulocyte activation in two different types of heparinized extracorporeal circuits. J Thorac Cardiovasc Surg 1995; 110:1623-1632.
50. Lundblad R, Moen O, Fosse E. Endothelin-1 and neutrophil activation during heparin-coated cardiopulmonary bypass. Ann Thorac Surg 1997; 63:1361-1367.
51. Hogevold HE, Moen O, Fosse E, Venge P, Braten J, Andersson C, Lyberg T. Effects of heparin coating on the expression of CD11b, CD11c and CD62L by leucocytes in extracorporeal circulation in vitro. Perfusion 1997; 12:9-20.
52. Jansen PG, te Velthuis H, Wildevuur WR, Huybregts MA, Bulder ER, van der Spoel HI, Sturk A, Eijsman L, Wildevuur CR. Cardiopulmonary bypass with modified fluid gelatin and heparin coated circuits. Br J Anaesth 1996; 76:13-19.
53. Wan S, DeSmet JM, Barvais L, Goldstein M, Vincent JL, LeClerc JL. Myocardium is a major source of proinflammatory cytokines in patients undergoing cardiopulmonary bypass. J Thorac Cardiovasc Surg 1996; 112:806-811.
54. Karube N, Adachi R, Ichikawa Y, Kosuge T, Yamazaki I, Soma T. Measurement of cytokine levels by coronary sinus blood sampling during cardiac surgery with cardiopulmonary bypass. ASAIO J 1996; 42:M787-M791.
55. Sablotzki A, Welters I, Lehmann N, Menges T, Gorlach G, Dehne M, • Hempelmann G. Plasma levels of immunoinhibrtory cytokines interleukin-10 and transforming growth factor-beta in patients undergoing coronary artery bypass grafting. Eur J Cardiothorac Surg 1997; 11:763-768. The potential importance of TGF-β is described.
56. Stefano GB, Rodriguez M, Glass R, Cesares F, Hughes TK, Bilfinger TV. Hyperstimulation of leukocytes by plasma from cardiopulmonary bypass patients is diminished by morphine and IL-10 pretreatment. J Cardiovasc Surg 1995 36:25-30.
57. Wan S, LeClerc JL, SchmartzD, Barvais L, Huynh CH, Deviere J, DeSmet •• JM, Vincent JL. Hepatic release of interleukin-10 during cardiopulmonary bypass in steroid-pretreated patients. Am Heart J 1997; 133:335-339. The importance of the liver as a source of IL-10 is shown and mechanisms for IL-10 generation are discussed.
58. Le Moine O, Marchant A, Durand F, Ickx B, Pradier O, Belghiti J, et al.. Systemic release of interleukin-10 during orthotopic liver transplantation. Hepatology 1994; 20:889-892.
59. Karres I, Kremer JP, Steckholzer U, Kenney JS, Ertel W. Transforming growth factor-beta 1 inhibits synthesis of cytokines in endotoxin-stimulated human whole blood. Arch Surg 1996; 131:1310-1316.
60. Kawamura T, Wakusawa R, Inada K. Interleukin-10 and interleukin-1 receptor antagonists increase during cardiac surgery. Can J Anaesth 1997; 44:38-42.
61. Tabardel Y, Duchateau J, Schmartz D, Marecaux G, Shahla M, Barvais L, et al.. Corticosteroids increase blood interleukin-10 levels dunng cardiopulmonary bypass in men. Surgery 1996; 119:76-80.
62. Wan S, Marchant A, DeSmet JM, Antoine M, Zhang H, Vachiery JL, et al.. Human cytokine responses to cardiac transplantation and coronary artery bypass grafting. J Thorac Cardiovasc Surg 1996; 111:469-477.
63. Sorohan J, McBride WT, Atwell D, Grichnik KP, Reves JG, Newman MD. The balance of pro- and anti-inflammatory cytokines at cardiac transplant surgery [abstract]. Anesth Analg 1997; 84:SCA19.
64. Wan S, DeSmet JM, Antoine M, Goldman M, Vincent JL, LeClerc JL. Steroid administration in heart and heart-lung transplantation: is the timing adequate? Ann Thorac Surg 1996; 61:674-678.
65. Journois D, Israel-Biet D, Pouard P, Rolland B, Silvester W, Vouhe P, Safran D. High-volume, zero-balanced hemofiltration to reduce delayed inflammatory response to cardiopulmonary bypass in children. Anesthesiology 1996; 85:965-976.